Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Cash from Investing Activities (2022 - 2025)

Coya Therapeutics' Cash from Investing Activities history spans 3 years, with the latest figure at -$25000.0 for Q1 2024.

  • For Q1 2024, Cash from Investing Activities changed N/A year-over-year to -$25000.0; the TTM value through Dec 2024 reached -$25000.0, changed N/A, while the annual FY2024 figure was -$25000.0, 95.4% up from the prior year.
  • Cash from Investing Activities for Q1 2024 was -$25000.0 at Coya Therapeutics, up from -$193186.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$25000.0 in Q1 2024 and bottomed at -$390000.0 in Q4 2022.
  • The 3-year median for Cash from Investing Activities is -$193186.0 (2023), against an average of -$202728.7.
  • The largest YoY upside for Cash from Investing Activities was 50.47% in 2023 against a maximum downside of 50.47% in 2023.
  • A 3-year view of Cash from Investing Activities shows it stood at -$390000.0 in 2022, then soared by 50.47% to -$193186.0 in 2023, then soared by 87.06% to -$25000.0 in 2024.
  • Per Business Quant, the three most recent readings for COYA's Cash from Investing Activities are -$25000.0 (Q1 2024), -$193186.0 (Q4 2023), and -$390000.0 (Q4 2022).